Journal article
1045 Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC)
Authors
Rusthoven J; Eisenhauer E; Butts C; Gregg R; Dancey J; Fisher B; Iglesias J
Journal
European Journal of Cancer, Vol. 33, ,
Publisher
Elsevier
Publication Date
September 1, 1997
DOI
10.1016/s0959-8049(97)85830-3
ISSN
0959-8049